KR20110090443A - Cosmetic composition containing omandungui glycosaminoglycan extracts for skin regeneration - Google Patents
Cosmetic composition containing omandungui glycosaminoglycan extracts for skin regeneration Download PDFInfo
- Publication number
- KR20110090443A KR20110090443A KR1020100010215A KR20100010215A KR20110090443A KR 20110090443 A KR20110090443 A KR 20110090443A KR 1020100010215 A KR1020100010215 A KR 1020100010215A KR 20100010215 A KR20100010215 A KR 20100010215A KR 20110090443 A KR20110090443 A KR 20110090443A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- glycosaminoglycan
- skin
- gag
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/655—Aquatic animals other than those covered by groups A61K35/57 - A61K35/65
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Oceanography (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 오만둥이에서 추출한 글리코사미노글리칸 복합물을 함유하는 피부재생 화장료 조성물에 관한 것으로, 해양생물을 이용한 화장품으로는 해양 생물 중 갑각류를 이용한 키틴 키토산 등이 있으며 해양 무척추 동물을 이용하여 화장품 소재로 최근 관심을 얻고 있는 것으로 글리코사미노글리칸이 있다. The present invention relates to a skin regenerating cosmetic composition containing a glycosaminoglycan complex extracted from an oar, and cosmetics using marine life include chitin chitosan using crustaceans among marine life and cosmetic materials using marine invertebrates. One that has recently gained attention is glycosaminoglycans.
글리코사미노글리칸은 동물의 결합조직에 함유된 산성 뮤코다당류 (muco polysaccharides)이며, D-glucouronic acid와 황산화된 N-acetylgalactosamine의 이당류의 반복구조로 구성되는데, 구성 당의 히드록시기의 황산화에 의하여 많은 종류의 다양한 이성체가 존재한다. 글리코사미노글리칸은 이러한 구조적인 차이에 따라 히알루론산, 더마탄 설페이이트, 콘드로이친 설페이트, 헤파린 등이 있다. 콘드로이틴황산을 포함하는 프로테오글리칸은 퇴행성관절염 예방 및 치료와 노화방지, 항종양 등의 기능성이 밝혀져 식품첨가물 및 의약품으로써 이용되고 있다. 콘드로이친 황산은 피부, 장기, 근육 등에 수분과 영양소를 축적하는 성질이 있어 피부 노화의 원인인 피부 수분과 영양소의 함량 저하를 억제하여 피부 노화를 지연시킬 수 있는 우수한 소재가 될 수 있다.
Glycosaminoglycans are acidic mucopolysaccharides contained in the connective tissues of animals and consist of a repeating structure of D-glucouronic acid and disaccharides of sulfated N-acetylgalactosamine. There are many kinds of different isomers. Glycosaminoglycans include hyaluronic acid, dermatan sulfate, chondroitin sulfate, and heparin according to these structural differences. Proteoglycans, including chondroitin sulfate, have been used as food additives and medicines because they have been found to prevent and treat degenerative arthritis, to prevent aging and antitumor. Chondroitin sulfate has the property of accumulating moisture and nutrients in skin, organs, muscles, etc., and can be an excellent material that can delay skin aging by inhibiting the decrease of skin moisture and nutrient content that causes skin aging.
(문헌1)콘드로이친황산을 함유하는 해삼 추출물의 제조방법(대한민국특허0167831)(Document 1) Method for preparing sea cucumber extract containing chondroitin sulfate (Korea Patent 0167831)
(문헌2) 미색류 껍질로부터 황산다당류의 추출 및 정제방법(대한민국 특허 10-0229948)
(Document 2) Extraction and Purification of Sulfate Polysaccharides from Off-White Peel (Korean Patent 10-0229948)
그동안 콘드로이틴황산의 공급 원료로서는 소와 돼지와 같은 육상 포유동물의 연골에서 추출한 제품이 그 대부분을 차지하고 있었으나, 광우병, 구제역과 같은 발병으로 인해 소비자로 부터 기피되고 있다. 이러한 이유로 다른 소재로부터 글리코사미노글리칸을 얻기 위한 많은 연구가 진행되고 있다. 그래서 본 발명자는 국내에서 생산되는 해양 무척추 동물 중 오만둥이를 시료로 하여 오만둥이에 함유된 글리코사미노글리칸을 추출하여 노화방지 화장품의 원료로 개발하고자 하였다.As a feedstock for chondroitin sulfate, most products are extracted from cartilage of terrestrial mammals such as cattle and pigs, but they are avoided by consumers due to diseases such as mad cow disease and foot and mouth disease. For this reason, many studies have been conducted to obtain glycosaminoglycans from other materials. Thus, the present inventors have attempted to develop glycosaminoglycans contained in the nests of the marine invertebrates produced in Korea as a sample and develop them as raw materials for anti-aging cosmetics.
그래서 본 발명자는 우리나라 남해안 청정지역에서 자라는 오만둥이는 그 성장률이 매우 빨라 생산량도 많을뿐더러 가격도 다른 해양 무척추동물에 비하여 싼 편이다. 이러한 오만둥이로 부터 글리코사미노글리칸을 추출하였다.Therefore, the present inventors grow in the clean area of the south coast of Korea, the growth rate is very fast, the production volume is high, and the price is also cheap compared to other marine invertebrates. Glycosaminoglycans were extracted from these halves.
본 발명의 목적은 해양무척추동물 중 오만둥이에서 추출한 글리코사미노글리칸 복합물의 새로운 용도를 제공하는 것이다. It is an object of the present invention to provide a novel use of glycosaminoglycan complexes extracted from halves of marine invertebrates.
다른 면으로, 본 발명의 목적은 활성성분으로 오만둥이에서 추출한 글리코사미노글리칸 복합물이 함유된 화장료 조성물을 제공하는 것이다. In another aspect, it is an object of the present invention to provide a cosmetic composition containing a glycosaminoglycan complex extracted from a snag as an active ingredient.
또 다른 면으로, 본 발명의 목적은 피부 재생, 보습효과를 가진 화장료 조성물을 제공하는 것이다.In another aspect, an object of the present invention is to provide a cosmetic composition having a skin regeneration, moisturizing effect.
상기한 바와 같이 본 발명에 의해 제조된 오만둥이 GAG 추출물은 피부 재생효과가 우수하며, 피부 보습효과가 뛰어나 피부 노화를 지연하는 효과를 나타낸다. 또한 남해안 청정지역인 통영에서 채취한 오만둥이 GAG 추출물은 피부 안정성도 탁월하고, 피부에 무자극인 장점을 가진 물질이다.
As described above, Omani GAG extract prepared by the present invention is excellent in skin regeneration effect, excellent skin moisturizing effect and exhibits the effect of delaying skin aging. In addition, Omani GAG extract from Tongyeong, a clean area of the south coast, has excellent skin stability and has no merit for skin.
본 발명은 오만둥이로부터 글리코사미노글리칸 복합물을 추출하여 이 추출물을 화장료 조성물로 이용한다. 상기 “글리코사미노글리칸 복합물”이란, 글리코사미노글리칸 및 기타 물질을 포함하여 이루어진 물질을 의미한다. 본 발명에서 기타 물질은 “ 당질, 단백질 및 회분”등으로 이루어진 물질이다. The present invention extracts the glycosaminoglycan complex from the snag and uses the extract as a cosmetic composition. As used herein, the term "glycosaminoglycan complex" refers to a substance comprising glycosaminoglycan and other substances. In the present invention, other substances are substances consisting of "saccharides, proteins and ash" and the like.
상기 오만둥이로부터 추출한 글리코사미노 복합물은 조성물 총 중량에 대하여 0.1 내지 30 중량%로 포함될 수 있다. 상기 글리코사미노 글리칸 복합물의 함량이 0.01 중량% 미만이면 피부재생 효과, 보습 효과 등이 거의 나타나지 않는 문제점이 발생할 수 있다. 50 중량%를 초과하는 경우에는 화장품으로의 제조가 적합하지 않은 문제점이 발생할 수 있다.Glycosamino complexes extracted from the halves may be included in an amount of 0.1 to 30% by weight based on the total weight of the composition. When the content of the glycosamino glycan complex is less than 0.01% by weight, there may be a problem in that a skin regeneration effect, a moisturizing effect, etc. are hardly shown. If it exceeds 50% by weight, a problem may arise that the manufacture of cosmetics is not suitable.
본 발명의 화장료 조성물은 이 기술 분야에서 통상적으로 제조되는 어떠한 형태의 제형으로든지 제조될 수 있다. 예를 들면, 유연 화장수, 수렴 화장수, 영양 화장수, 영양크림, 아이크림, 마사지 크림, 에센스, 파우더 및 팩으로 이루어진 피부 외용제형 기초 화장품으로 구성되는 군으로부터 그 제형을 선택할 수 있으나, 반드시 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may be prepared in any form of formulation commonly prepared in the art. For example, the formulation may be selected from the group consisting of skin cosmetics based on flexible skin lotion, astringent lotion, nourishing lotion, nourishing cream, eye cream, massage cream, essence, powder and pack, but is not limited thereto. It is not.
통영소재 중앙시장에서 구입한 오만둥이는 맑은 물이 나올 때까지 흐르는 물로 세정하였다. 이 시료를 고압 증기솥(동남산업, DN-1001)에 넣고 시료량의 5~10배의 물을 가하였다. 그 다음 100~130℃의 온도에서 2~5시간 동안 증자하였다. 실온으로 될 때까지 방치한 다음, 3,000 rpm에서 20분간 원심분리(Hanil Scentific Industrial, MF 600 PLUS, Large Capacity Centrifuge)하였다. 가라앉은 침전물은 버리고 상등액을 취하여 brix 10이 될 때까지 농축진공 회전 증발기(Rotary Evaporator; Hahn Shin Scentific, Model No. 20sp)로 농축하였다. 함유된 단백질을 제거하기 위해 50~80%의 암모늄설페이트를 가해 냉장상태(0~10℃)에서 24시간동안 방치하였다. 이것을 3,000rpm에서 20분간 원심분리 하고 여과하였다. 염의 함량이 0.1%이하로 될 때까지 증류수로 상등액을 투석하였다. 이 용액을 Brix 10이 될 때까지 농축하였다. 농축한 량의 3~7배의 알코올을 가하여 글리코사미노글리칸을 침전시켰다. 이 침전물을 3,000rpm에서 20분간 원심분리하여 동결 건조(FDU-540, Tokyo Rikakikai Co., Ltd, Tokyo, Japan)하여 오만둥이 글리코사미노글리칸 추출물로 하였다. 이러한 과정을 통해 얻은 오만둥이 글리코사미노글리칸 복합물의 수율은 0.80%였다. Omani purchased from Tongyeong Central Market was washed with running water until clear water came out. The sample was placed in a high pressure steam cooker (Dongnam Industrial Co., DN-1001) and water 5-10 times the sample volume was added thereto. Then, the mixture was cooked for 2 to 5 hours at a temperature of 100 to 130 ° C. It was allowed to stand at room temperature and then centrifuged at 3,000 rpm for 20 minutes (Hanil Scentific Industrial, MF 600 PLUS, Large Capacity Centrifuge). The settled precipitate was discarded and the supernatant was taken and concentrated with a rotary evaporator (Hahn Shin Scentific, Model No. 20sp) until brix 10. 50-80% ammonium sulphate was added to remove the contained protein and left for 24 hours in refrigerated condition (0-10 ° C). It was centrifuged at 3,000 rpm for 20 minutes and filtered. The supernatant was dialyzed with distilled water until the salt content was less than 0.1%. This solution was concentrated to Brix 10. Three to seven times the concentrated amount of alcohol was added to precipitate glycosaminoglycans. The precipitate was centrifuged at 3,000 rpm for 20 minutes to be lyophilized (FDU-540, Tokyo Rikakikai Co., Ltd, Tokyo, Japan) to obtain Oman glycosaminoglycan extract. The yield of Omani glycosaminoglycan complex obtained through this process was 0.80%.
추출물 중의 글리코사미노글리칸의 함량은 식품공전법에 준하여 uronic acid의 함량을 측정하여 환산하는 방법인 Carbazole assay법에 따라 시행한 결과 약 10%였다.
The content of glycosaminoglycans in the extract was about 10% according to the Carbazole assay, a method of measuring and converting uronic acid content according to the Food Code.
(실시예) (Example)
오만둥이에서 추출한 글리코사미노글리칸(이하 GAG)를 함유한 미용액의 제조Preparation of Serum Containing Glycosaminoglycans (hereinafter referred to as GAG) Extracted from Omanis
위의 방법으로 제조한 오만둥이 GAG 동결건조물 2g과 3g을 정제수 각각 68ml 67ml에 가하고 350rpm으로 65℃에서 용해하였다. 프로필렌 글리콜 10g과 글리세린 20g을 위 용액에 첨가하고 여기에 방부제(Gsilk-P350, GFC Co. Ltd, Korea)를 넣어 1,200 rpm으로 40~60℃에서 20분간 용해하였다. 실온에 방치한 후 0.25um 여과지로 여과한 여과액을 2% 및 3% 글리코사미노글리칸 미용액으로 하였다.
2 g and 3 g of Omani GAG lyophilisate prepared by the above method were added to 68 ml of 67 ml of purified water, respectively, and were dissolved at 65 ° C. at 350 rpm. 10 g of propylene glycol and 20 g of glycerin were added to the above solution, and a preservative (Gsilk-P350, GFC Co. Ltd, Korea) was added thereto and dissolved at 40 to 60 ° C. for 20 minutes at 1,200 rpm. After standing at room temperature, the filtrate filtered with 0.25um filter paper was used as 2% and 3% glycosaminoglycan cosmetic liquid.
(2%GAG 미용액)Example 1
(2% GAG serum)
(3%GAG 미용액)Example 2
(3% GAG serum)
(시험예 1) (Test Example 1)
-시료의 독성시험 - toxicological testing of samples
시료의 독성을 알아보고자 RAW 264.7 세포로 독성시험을 실시하였다. 독성의 여부를 알아보기 위하여 오만둥이 GAG 복합물을 배지에 각각 1ug/ml, 50ug/ml, 100ug/ml 및 200ug/ml의 최종농도로 조제하였고, 시험결과 모든 농도의 시료에서 독성은 나타나지 않았으며, 오히려 시료를 처치하지 않은 대조군에 비해 세포의 생장이 증가하여 세포의 성장을 촉진함으로써 피부세포의 재생효과에 기여할 수 있을 것으로 기대된다.
To determine the toxicity of the sample, a toxicity test was conducted with RAW 264.7 cells. To determine the toxicity, Omani GAG complexes were prepared in medium at final concentrations of 1 ug / ml, 50 ug / ml, 100 ug / ml and 200 ug / ml, respectively. Rather, it is expected that the growth of the cells may be increased to promote the growth of the cells, thereby contributing to the regeneration effect of the skin cells, compared to the control without the sample.
(시험예 2)(Test Example 2)
-피부섬유아세포의 재생 효과 - Playback effects of skin fibroblasts
피부의 재생효과를 확인하기 위하여 Human dermal fibroblast cell(CCD986sk)을 한국세포주은행에서 구입하여 15% 송아지 혈청(FBS; Gibco)를 포함한 DMEM(Gibco) 배지로 배양하였다. 이 세포를 96well plate에 4000 cells/well로 분주하고, 24시간 후 오만둥이에서 추출한 GAG를 농도별로 10% FBS를 함유한 세포배양 배지에 처리하였다. 2-3일에 1번씩 시료를 포함한 배지를 교환해 주면서, 7일간 배양한 후 세포의 증식률을 MTS〔3-(4,5-dimethyl-thiazol-2-yl)-5-carboxy-methoxyphenyl -2-(4-sulfophenyl)-2H-tetrazolium〕시약을 1시간동안 처리한 후 마이크로플레이트 리더기(Perkin Elmer 1420 Multilabel Counter VICTORTM, USA)로 490nm에서 흡광도를 측정하였다. 세포의 생존률은 대조군에 대비한 시료 처리군의 흡광도로 표시하였다. Human dermal fibroblast cells (CCD986sk) were purchased from Korea Cell Line Bank and cultured with DMEM (Gibco) medium containing 15% calf serum (FBS; Gibco). The cells were dispensed at 4000 cells / well in 96-well plates, and after 24 hours, GAGs extracted from the hounds were treated with cell culture medium containing 10% FBS. Incubate for 7 days, replacing the medium containing the sample once every 2-3 days, and then determine the proliferation rate of the cells by MTS [3- (4,5-dimethyl-thiazol-2-yl) -5-carboxy-methoxyphenyl-2 -(4-sulfophenyl) -2H-tetrazolium] reagent was treated for 1 hour and absorbance was measured at 490 nm with a microplate reader (Perkin Elmer 1420 Multilabel Counter VICTORTM, USA). Cell viability was expressed as absorbance of the sample treated group compared to the control.
*p<0.5, **p<0.01
* p <0.5, ** p <0.01
(시험예 3)(Test Example 3)
-피부 보습 효능의 측정 - measurement of skin moisturizing effect
실내온도 22~24℃, 상대습도 55%, 공기의 흐름이 없는 실내에서 건강한 피부를 가진 남녀 10명을 대상으로 GAG의 보습효능을 측정해 보았다. 먼저 피실험자의 손목위 팔 부분에 지름 2.5cm의 원으로 세부분을 표시하고 시료 도포전의 피부 수분함량을 측정하였다. 측정 후 표시한 부분 각각에 오만둥이 GAG를 함유하지 않은 대조군, 오만둥이 GAG를 함유한 2% 미용액과 3%미용액 40ul를 피부에 도포하였다. 도포직후, 30분후, 1시간후 2시간후에 표시한 부분의 피부의 수분 함량을 측정해 보았다. 피부의 수분함량은 피부진단기 아라모-Ts(Aramhuvis, Korea)를 이용하여 보습효과의 지속성을 측정하였다.
We measured the moisturizing effect of GAG on 10 men and women with healthy skin at room temperature 22 ~ 24 ℃, relative humidity 55% and no air flow. First, the details were marked with a circle of 2.5cm in diameter on the arm of the subject's wrist and the skin moisture content was measured before sample application. After the measurement, each of the marked areas was coated with a control group containing no hummingbird GAG, 2% cosmetic liquid containing hummingbird GAG and 40ul of 3% unsolvent. Immediately after application, 30 minutes later, and 1 hour later, 2 hours later, the water content of the skin was measured. The moisture content of the skin was measured using the skin diagnostic device Aramo-Ts (Aramhuvis, Korea) to measure the persistence of the moisturizing effect.
*p<0.5, **p<0.01
* p <0.5, ** p <0.01
(시험예 4)(Test Example 4)
-피부자극도 실험Skin irritation test
오만둥이 GAG 미용액의 피부 자극성을 알아보기 위하여 인체 첩포 시험을 실시하였다. 건강한 성인 남녀 10명의 상박 동일 부위에 대조구와 2%, 3% GAG를 24시간 첩포하였다. 24시간의 첩포후 이를 제거하고 피부자극을 측정하고, 24시간 및 48시간 경과 후에 피부 자극을 또한 측정하였다. 본 결과에 의하면 본 발명에 따른 오만둥이 GAG 미용액의 피부자극은 매우 미미한 것으로 판명되었다.
Human patch test was performed to investigate the skin irritation of the GAG serum. Ten healthy men and women were patched with control and 2% and 3% GAG for 24 hours. After 24 hours of patching it was removed and skin irritation measured and skin irritation was also measured after 24 and 48 hours. According to the results, it was proved that the skin irritation of the gigantic GAG essence liquid according to the present invention was very insignificant.
++ 심하게 붉어짐 ++ badly reddened
+ 약간 붉다가 없어짐 + Slightly reddish
- 무반응
-No response
Claims (5)
Cosmetic composition, characterized in that extracted from the invertebrates of marine invertebrates put water corresponding to 1 ~ 10 times of the sample in the extractor and heated for 5 hours at 100 ~ 130 ℃ 2 hours
Cosmetic composition containing the one obtained by treating with 50-80% ammonium sulfate to remove protein from the extract of claim 1
Cosmetic composition containing the obtained by drying the precipitate produced by the process of Claims 1 and 2 by 3-7 times alcohol.
Cosmetic composition, characterized in that it comprises 0.01 to 30% by weight of the gigantic glycosaminoglycan extract based on the total weight of claim 1, 2, 3
The cosmetic composition is a cosmetic composition characterized in that the formulation of the lotion, nourishing lotion, nourishing cream, massage cream, nourishing essence, massage pack or emulsified foundation (can I have no content?)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100010215A KR20110090443A (en) | 2010-02-04 | 2010-02-04 | Cosmetic composition containing omandungui glycosaminoglycan extracts for skin regeneration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100010215A KR20110090443A (en) | 2010-02-04 | 2010-02-04 | Cosmetic composition containing omandungui glycosaminoglycan extracts for skin regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110090443A true KR20110090443A (en) | 2011-08-10 |
Family
ID=44928225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100010215A KR20110090443A (en) | 2010-02-04 | 2010-02-04 | Cosmetic composition containing omandungui glycosaminoglycan extracts for skin regeneration |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110090443A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160082714A (en) | 2014-12-26 | 2016-07-11 | 부산대학교 산학협력단 | Cosmetic composition for skin whitening and anti-aging containing styela clava tunic extract |
-
2010
- 2010-02-04 KR KR1020100010215A patent/KR20110090443A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160082714A (en) | 2014-12-26 | 2016-07-11 | 부산대학교 산학협력단 | Cosmetic composition for skin whitening and anti-aging containing styela clava tunic extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116003577B (en) | Recombinant collagen for skin soothing and repairing and application thereof | |
EP2666467A1 (en) | Extract of aquatic animal cartilage | |
CN105663020A (en) | Spraying water with long-acting moisture-preserving capacity and preparation method thereof | |
CN103845273A (en) | Lumbricus peptide capable of resisting skin aging as well as preparation method and application thereof | |
CN101961298B (en) | Moisturizing composition | |
JP2019023218A (en) | Method for acquiring mixture of neutral oligosaccharides extracted from flaxseed | |
KR101525876B1 (en) | Method for making glue from donkey skin and cosmetics containing the same | |
CN113208998A (en) | Anti-wrinkle essence containing stem cell exosomes | |
CN109875940A (en) | A kind of preparation method and skin barrier reparation application of the Essence containing beta glucan | |
TWI701033B (en) | Bundling energy enhancer of collagen fiber | |
KR101552472B1 (en) | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity | |
CN109481344A (en) | A kind of plant polyose composition and its application | |
KR20110090443A (en) | Cosmetic composition containing omandungui glycosaminoglycan extracts for skin regeneration | |
He et al. | Components and Antioxidant Activity of the Polysaccharide from Streptomyces virginia H03 | |
WO2012169818A2 (en) | Cosmetic composition containing aplysia kurodai extracts for skin moisturizing and anti-wrinkling | |
JP5705397B2 (en) | Use of substances to protect FGF-2 or FGF-β growth factors | |
KR20080079489A (en) | Cosmetic compositions containing hollyhock extracts | |
KR20180124443A (en) | Cosmetic composition for enhancing skin barrier containing extract of Tremella fuciformis fruiting body | |
KR20180124438A (en) | Cosmetic composition comprising oligo-hyaluronic acid exhibiting up-regulation of aquaporin-3 and anti-inflammatory effect | |
Yao et al. | Skin Health Promoting Effects of Natural Polysaccharides and Their Potential Application in Cosmetic Industry. Polysaccharides 2022, 3, 818–830 | |
KR101114006B1 (en) | Composition for cosmetic or plastic surgery containing the extracts of Hedyotidis Diffusae Herba | |
CN117815110B (en) | Moisturizing, soothing and whitening plant compound polysaccharide and preparation method and application thereof | |
KR101340478B1 (en) | Cosmetic composition including water-soluble sericin from silk-gland powder of silkworm | |
US10022317B2 (en) | Composition comprising an extract of herbal medicine processed by an oriental herbal medicine processing | |
KR102161269B1 (en) | Cosmetic composition composed of including extracts magnolia bark rind extract drynaria fortunei and cosmetics using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |